"Topoisomerase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit the activity of DNA TOPOISOMERASES.
| Descriptor ID |
D059003
|
| MeSH Number(s) |
D27.505.519.389.892 D27.505.954.248.794
|
| Concept/Terms |
Topoisomerase Inhibitors- Topoisomerase Inhibitors
- Inhibitors, Topoisomerase
- DNA Topoisomerase Inhibitors
- Inhibitors, DNA Topoisomerase
- Topoisomerase Inhibitors, DNA
|
Below are MeSH descriptors whose meaning is more general than "Topoisomerase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Topoisomerase Inhibitors".
This graph shows the total number of publications written about "Topoisomerase Inhibitors" by people in this website by year, and whether "Topoisomerase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Topoisomerase Inhibitors" by people in Profiles.
-
Identification of Doxorubicin as an Inhibitor of the IRE1a-XBP1 Axis of the Unfolded Protein Response. Sci Rep. 2016 09 16; 6:33353.
-
Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies. Cancer Biol Ther. 2014 Jul; 15(7):851-61.
-
DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIa inhibitor. Mol Pharmacol. 2011 Aug; 80(2):321-7.
-
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res. 2004 Apr 01; 10(7):2319-26.